Skip to content
FDA drug shortage status

Is Leuprolide Acetate Injection in shortage?

Leuprolide Acetate Injection is listed by FDA as being discontinued by at least one maker (updated Oct 20, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Leuprolide Acetate, Injection, 14 mg/2.8 mL (1 mg/0.2 mL) (NDC 70121-2537-6)
    Amneal PharmaceuticalsBeing discontinuedUpdated Oct 20, 2026Discontinued Oct 20, 2026

    A business decision was made to discontinue manufacture of the drug.

    Maker contact: 866.525.7270

Leuprolide Acetate Injection shortage questions

Is Leuprolide Acetate Injection in shortage?

Leuprolide Acetate Injection is listed by FDA as being discontinued by at least one maker (updated Oct 20, 2026).

What should I do if I can’t get Leuprolide Acetate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.